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Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a
novel bunyavirus (SFTSV) in China. Humans of all ages living in endemic areas have high risk of acquiring SFTS.
Most clinical data so far have been from adults and no clinical study was available from children yet. The present
study identified four SFTSV infected children through hospital based surveillance. A prospective observational study
was performed to obtain their clinical and laboratory characteristics.
Case presentation: The patients’ age ranged from 4–15 years old and two were male. On hospitalization, fever,
malaise and gastrointestinal syndromes were the most commonly presenting symptoms. Hemorrhagic symptoms
or neurological manifestation was not recorded in any of the four pediatric patients. Hematological abnormalities
at admission into hospital included leucopenia (4 cases), thrombocytopenia (1 case) and bicytopenia (1 case).
The abnormal parameters included elevated aminotransferase (1 case), alanine transaminase (2 case), and lactate
dehydrogenase (3 case). Laboratory parameters indicative of renal damage was not observed during the
hospitalization. All the patients recovered well without sequelae being observed.
Conclusion: Compared with adults, pediatric patients with SFTSV infection seem to have less vague subjective
complaints and less aggressive clinical course. Thrombocytopenia is suggested to be used less rigorously in
recognizing SFTSV infection in pediatric patients, especially at early phase of disease.
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Background
Severe fever with thrombocytopenia syndrome (SFTS) is
an emerging infectious disease caused by a novel bunya-
virus (SFTSV) that was firstly described in 2010 in China
[1], Outside China, confirmed SFTS or SFTS like pa-
tients had recently been reported in Korea, Japan, Dubai,
United Arab Emirates and Missouri, United States, sug-
gesting its expanded distribution in other countries [2-5]
The disease usually presents as fever, thrombocytopenia
and leukocytopenia, with case-fatality rates ranging from
2.5% to 30% [6]. Epidemiological investigation revealed
that SFTS cases mostly lived in rural areas working as
farmers, and their age ranged from 1 to 90, with most part
of cases (75%) older than 50 years old [1,5,6]. Although
pediatric patients under 18 years old were recorded, most
data available so far have been from adults and no clinical
study on children was performed yet.
Since 2011, we have performed a hospital based surveil-
lance on SFTSV infected cases in one SFTS-designated
hospital in Xinyang, Henan Province, China [7]. From the
same hospital, we identified four pediatric cases confirmed
to be infected with SFTSV by real-time reverse transcript-
ase polymerase chain reaction (RT-PCR) and subsequent
sequencing [7]. A prospective observational study was
performed to obtain their clinical and laboratory charac-
teristics from acute phase of infection until convales-
cence. Altogether 180 SFTSV infected adult patients
who had been hospitalized during the same period from
the same hospital were extracted for comparison with
these pediatric patients.
Case presentation
The median age of the pediatric patients was 8 (range 4–
15) years old and 2 were male. Two of the patients had
tick bite history during their outdoor activity. The other
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Table 1 Demographic and clinical characteristics of the children with SFTS in comparison with adult patients
Characteristics Pediatric patients Adult patients
(N = 180)Case1 Case2 Case3 Case4
Demographic features No. (%)/mean (SD)
Gender Male Female Female Male 80 male (44.4)
Age, y, 6 7 4 15 57.5 (13.0)
History of tick bite Yes No No Yes 29 (16.1)
Close contact with known SFTS patients No Yes Yes No 12 (6.7)
Mean (range)
Median days from syndromes to admission 3 7 5 4 5 (1–38)
Presenting with clinical manifestations on admission No. (%) of patients
Fever Yes Yes Yes Yes 177 (98.3)
Malaise Yes Yes Yes Yes 172 (95.6)
Myalgias No No No No 148 (82.2)
Gastrointestinal syndromes Yes Yes Yes No 116 (64.4)
Cough No No No No 63 (35.0)
Sputum production No No No No 46 (25.6)
Dizziness No No No No 42 (23.3)
Headache No No No No 35 (19.4)
Dyspnea No No No No 21 (11.7)
Arthralgias No Yes No No 13 (7.2)
Lymphadenopathy No Yes No No 78 (3.3)
Hematuria No No No No 33 (18.3)
Petechia No No Yes No 25 (13.9)
Hematemesis No No No No 13 (7.2)
Gingival bleeding No No No No 2 (1.1)
Melena No No No No 2 (1.1)
Consciousness disorder No No No No 36 (20.0)
Laboratory measurements on admission Mean ± SD
WBC (x109/L) 2.3* 1.83* 2.9* 3.3* 3.0 ± 2.3
PLT (x109/L) 118 87* 107 148 71.3 ± 34.6
Neutrophils (%) 52.9 41.7 37.3 72.5 62.0 ± 15.9
Lymphocyte (%) 32.7 43.7 58.1 19.2 29.1 ± 13.0
With abnormal laboratory tests on admission No. (%) of patients
AST >40 U/L No (14) Yes (521) No (18) No (39) 148 (82.2)
ALT >40 U/L No (32) Yes (178) Yes (55) No (19) 115 (63.9)
ALB <35 g/ No (48.3) No (42.5) No (45.5) No (44.4) 78 (45.6)
ALP >150 U/L Yes (289) Yes (239) Yes (191) No (132) 14 (8.2)
GGT >50 U/L No (10) Yes (52) No (13) No (15) 49 (27.2)
LDH >245 U/L Yes (250) Yes (545) Yes (320) No (236) 136 (75.6)
CK >232 U/L No (89) Yes (1167) No (94) Yes (1012) 128 (71.1)
BUN >7.8 mmol/L No (5.68) No (3.36) No (4.59) No (7.5) 45 (25.0)
CREA >97 mmol/L No (30) No (35) No (35) No (87) 41 (22.8)
Proteinuria No No No No 55 (30.6)
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two had close contacts with their SFTSV infected family
members, which is a higher frequency than in adults
(6.7%). All the pediatric patients were otherwise healthy
and had no previous co-morbidity. The delay from disease
onset to hospital entrance was 3–7 days, comparable with
that of adults (mean 5 days). On hospitalization, fever,
malaise and gastrointestinal syndromes were the most
commonly presenting symptoms. This is similar with the
results that were obtained from adult patients (Table 1).
No syndromes of dyspnea, headache, consciousness dis-
order, dizziness, sputum production, cough or myalgias
were observed from the pediatric patients, which were
presented with frequencies ranging from 11.7% to 82.2%
in adult patients. Hemorrhagic symptoms (hematuria,
petechia, hematemesis, gingival bleeding, melena), which
were manifested in adult patients were rarely found in
these pediatric patients, except for the presence of petechia
in case 1. No neurological manifestation was recorded in
any of the four pediatric patients.
For the laboratory tests, hematological abnormalities
at admission into hospital included leucopenia (4 cases),
thrombocytopenia (1 case) and bicytopenia (1 case). The
abnormal parameters indicative of liver damage, for ex-
ample, aspartate aminotransferase (AST), alanine trans-
aminase (ALT), and lactate dehydrogenase (LDH) were
presented in one, two and three patients, respectively.
The frequencies in adults ranged from 63.9% (ALT) to
82.2% (AST). None of the pediatric patients had elevated
albumin (ALB), blood urea nitrogen (BUN), creatinine
(CREA), or presence of proteinuriay, which were mostly
indicative of renal damage. These abnormalities were
present in 45.6%, 25%, 22.8% and 30.6% among adult pa-
tients, respectively. At the end of clinical course, all pa-
tients presented different degree of neutropenia.
The pediatric patients had peak temperature of 38.8°C
after hospitalization, declining to normal level at 4–8
days post disease onset. In contrast, the estimated median
fever course in adult patients was 2 days (Figure 1A). The
dynamic evaluations of PLT revealed a delayed occurrence
of thrombocytopenia in three patients (5–6 days after dis-
ease onset) than that of the adults (mean 1–2 days). In
addition, the recovery of PLT to normal levels was earlier
than that of the adults (5–9 vs 10 days). The nadir levels
of WBC counts in all the 4 children were lower than the
mean level of adults at the same time points post infec-
tion, yet with a more rapid recovery than that of adults in
case 1, 2 and 4 (Figure 1C).
For the other four abnormal indicators, AST and CK
were maintained at significantly lower level than the adults
(Figure 1C and G), and case 1 additionally had lower level
of ALT (Figure 1E). Similar patterns were observed be-
tween pediatric and adult patients for other evaluations
(Figure 1D-G). It’s noteworthy that for case 3 and case
4, ALT and AST levels were normal on admission, only
elevated to abnormal during the follow-up period. Dur-
ing the whole hospitalization, all the pediatric patients had
normal BUN, CREA and ALB levels and no hemo-
rrhagic symptoms other than petechia developed (data
not shown).
At 2-month revisit to the hospital, the patients remained
healthy without sequelae. patient 2 and patient 3 devel-
oped antibody titers of 1:160 and 1:640 by enzyme-linked
immunosorbent assay (ELISA) using the recombinant nu-
cleoprotein of SFTSV [7]. In comparison, the IgG anti-
body titers of their household members from whom the
infection was acquired were both 1:320. The other two
pediatric patients failed to be revisited on the 2-month
revisit.
Discussion and conclusions
In the current study, no death occurred among 4 pediatric
patients and their clinical manifestation appeared to be
milder than those of the adult patients. Apart from fever
and gastrointestinal syndromes, the pediatric patients pre-
sented with less vague subjective complaints, as well as
rare hemorrhagic symptom which were more often pre-
sented in adult patients. This made the recognition of
pediatric SFTS cases more difficult than the adults, solely
based on clinical syndromes. According to the original
diagnosis criteria, a clinical SFTS patient was defined as
presenting both thrombocytopenia and lymphopenia [8].
However, thrombocytopenia is not evident until several
days after hospitalization according to the current finding
from pediatric patients. These patients might be missed if
diagnosed by the standard criteria. We therefore propose
that thrombocytopenia should be used less rigorously in
recognizing SFTSV infection in pediatric patients at early
phase of disease.
Table 1 Demographic and clinical characteristics of the children with SFTS in comparison with adult patients
(Continued)
Outcome
Recovery Yes Yes Yes Yes 144 (80.0)
Adverse Outcome No No No No 36 (20.0)
Death No No No No 25 (13.9)
*Denotes abnormal value.
Abbreviations: WBC white blood cell, PLT platelet, HGB hemoglobin, AST aspartate aminotransferase, ALT alanine transaminase, ALB albumin, ALP alkaline
phosphatase, GGT gamma-glutamyl transpeptidase, LDH lactate dehydrogenase, CK creatine kinase, BUN blood urea nitrogen, CREA Creatinine.
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Figure 1 Dynamic profiles of laboratory parameters in 4 SFTS pediatric patients in comparison with 180 adult patients. The laboratory
parameters include temperature (A), platelet counts (B), white blood cell counts (C), aspartate aminotransferase (AST) (D), alanine transaminase
(ALT) (E), lactate dehydrogenase (LDH) (F), creatine kinase (CK) (G) and SFTSV viral loads (H). Dynamic profiles were delineated using mean
(standard deviations) in A, B, C and H and median (P25-P75) in D, E, F and G. The lowest platelet counts (x109/L) in Figure 1B were 90,87, 62 and
50, respectively. The lowest WBC counts (x109/L) in Figure 1C were 2.2, 1.8, 1.6 and 1.7, respectively. The highest values of AST (U/L) in Figure 1D
were 14, 521, 54 and 188, respectively. The highest levels of ALT (U/L) in Figure 1E were 39, 236, 132 and 158, respectively. The normal ranges of
the laboratory parameters were delineated for children and adults separately. Only one range was marked if the normal ranges were the same for
children and adults.
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In clinical practice, the laboratory parameters indica-
tive of liver and renal damage were regularly used for
auxiliary diagnosis of SFTS. As displayed in the current
pediatric patients, laboratory parameters indicative of liver
damage (AST, ALT, LDH, CK), instead of renal damage
(BUN, CREA and ALB) was manifested. The evaluation of
AST, ALT, LDH and CK could play roles in the auxiliary
diagnosis; however they need to be used cautiously, as
these evaluations might not be elevated at early infection
and also kept at normal levels in certain pediatrics during
the whole hospitalization.
Disease severity of patients infected with SFTSV var-
ied, depending on multiple factors, including the viru-
lence of different strains, access to the health system, the
host factors, as well as other unknown reasons. Since
the current pediatric patients acquired infection from
the same region during the same period with adult pa-
tients, the impact from infected viral strain was sup-
posed to be minor. Moreover, the children have better
access to the health system. The comparably milder dis-
ease in pediatric patients therefore might be derived
from the host factor. Jin et al. have demonstrated that
virus replication and overexuberant immune responses
can contribute to progressive organ damage [9]. More-
over, dramatically elevated proinflammatory cytokine
levels have been detected in severe or fatally infected pa-
tients, suggestive of a cytokine storm might contribute
to the adverse disease outcome [10-12]. Children are
physically different with adults and the incomplete matur-
ation of the immune system could pose as one possible
mechanism underlying their milder disease manifestation
in comparison to adult patients [13]. This mechanism had
been applied in explaining the similarly milder clinical
course of Crimean–Congo hemorrhagic fever (CCHF) in
children than the adults [13].
The current study is subject to major limitation that
only observation study was made on four patients with-
out statistical analysis performed to draw validated con-
clusion. This needs to be addressed by study of large
sample size in the future.
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